A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2016
At a glance
- Drugs TAK 715 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 10 Jun 2017 Biomarkers information updated
- 06 Nov 2012 Planned number of patients (400) added as reported by European Clinical Trials Database record.
- 15 Oct 2008 New trial record.